and the anticipated launch of new treatments such as Olanzapine LAI (TEV-‘749), Iclepertin (BI-425809), Ulotaront (SEP-363856), Brilaroxazine (RP5063), and others during the forecast period.

In 2015, CMS implemented SEP-1 to promote timely sepsis care. SEP-1 requires clinicians to complete a well-defined set of interventions within 3 hours of recognizing sepsis. These steps include ...

“Though the west has not always been eager to embrace China as a partner or recognize its growing influence in the global economy, this is no longer a market that players in the SEP licensing ...

This article explores maximizing retirement savings through three popular retirement options designed specifically for small businesses and self-employed individuals—the SEP-IRA, Simple IRA and ...

Schizophrenia Companies in the market are Reviva Pharmaceuticals, Minerva Neurosciences, Karuna Therapeutics, Acadia Pharmaceuticals, Boehringer Ingelheim, Sunovion Pharmaceuticals (Sumitomo ...

NOTICE is hereby given that on September 11, 2024 and amended on November 8 ... NMPM, at a point where X=363,856 meters and Y=3,916,198 meters intersect, UTM Zone 13 North, NAD 83, in Sandoval County, ...

Ulotaront hydrochloride (SEP-363856, SEP-856) is under development for the treatment of schizophrenia, major depressive disorder, generalized anxiety disorder (GAD), Parkinson’s disease psychosis and ...

DelveInsight’s Schizophrenia Market Insights report includes a comprehensive understanding of current treatment practices, schizophrenia emerging drugs, market share of individual therapies ...

In this study, the researchers used cryo-electron microscopy (cryo-EM) to determine high-resolution structures of the human TAAR1-Gs protein complex simulated by METH, β-PEA, the selective agonist ...